Want to see CMPS full AI Analyst Report?
ETFs with COMPASS Pathways (CMPS) Exposure
The following ETFs maintain exposure to COMPASS Pathways (CMPS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
23 ETFs Hold COMPASS Pathways (CMPS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in CMPS |
|---|---|---|---|---|---|---|
| PSIL | AdvisorShares Psychedelics ETF | $46.62M | 1.00% | 11.97% | $5.59M | 0.33% |
| ARKG | Ark Genomic Revolution Ucits ETF AccumUSD | $123.47M | 0.79% | 2.90% | $4.00M | 0.24% |
| ARKG | ARK Genomic Revolution ETF | $2.37B | 0.75% | 2.64% | $58.53M | 3.65% |
| AADR | AdvisorShares Dorsey Wright ADR ETF | $35.14M | 1.09% | 1.86% | $677.75K | 0.04% |
| ORR | Militia Long/Short Equity ETF | $347.75M | 10.91% | 1.50% | $5.23M | 0.31% |
| SURI | Simplify Propel Opportunities ETF | $75.80M | 2.56% | 1.42% | $1.05M | 0.07% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 1.07% | $1.96M | 0.12% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | $114.88M | 0.68% | 0.93% | $1.06M | 0.06% |
| DOCT | Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD | $388.44M | 0.49% | 0.90% | $3.41M | 0.21% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.74% | $255.93K | 0.02% |
| ARKG | ― | ― | ― | 0.49% | $28.00K | <0.01% |
| TDNA | T. Rowe Price Biotech ETF | $11.32M | 0.55% | 0.44% | $49.28K | <0.01% |
| GWX | SPDR S&P International Small Cap ETF | $903.12M | 0.40% | 0.13% | $1.20M | 0.07% |
| ESIM | Eventide International ETF | $29.98M | 0.59% | 0.13% | $39.30K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.10% | $1.35M | 0.08% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.10% | $119.16K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.09% | $10.27M | 0.64% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | 0.08% | $15.46K | <0.01% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | $3.21B | 0.55% | 0.05% | $1.66M | 0.10% |
| KFOR | iShares II PLC - iShares UK Foreign Focus UCITS ETF Accum- GBP | $2.59M | 0.28% | 0.05% | $1,338.67 | <0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.02% | $241.93K | 0.01% |
| ISCF | iShares MSCI Intl Small-Cap Multifactor ETF | $719.78M | 0.23% | 0.02% | $143.33K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $572.95K | 0.03% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in CMPS |
|---|---|---|---|---|---|---|
| PSIL | 11.97% | AdvisorShares Psychedelics ETF | $46.62M | 1.00% | $5.59M | 0.33% |
| ARKG | 2.90% | Ark Genomic Revolution Ucits ETF AccumUSD | $123.47M | 0.79% | $4.00M | 0.24% |
| ARKG | 2.64% | ARK Genomic Revolution ETF | $2.37B | 0.75% | $58.53M | 3.65% |
| AADR | 1.86% | AdvisorShares Dorsey Wright ADR ETF | $35.14M | 1.09% | $677.75K | 0.04% |
| ORR | 1.50% | Militia Long/Short Equity ETF | $347.75M | 10.91% | $5.23M | 0.31% |
| SURI | 1.42% | Simplify Propel Opportunities ETF | $75.80M | 2.56% | $1.05M | 0.07% |
| SBIO | 1.07% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $1.96M | 0.12% |
| HTEC | 0.93% | ROBO Global Healthcare Technology and Innovation ETF | $114.88M | 0.68% | $1.06M | 0.06% |
| DOCT | 0.90% | Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD | $388.44M | 0.49% | $3.41M | 0.21% |
| BBC | 0.74% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $255.93K | 0.02% |
| ARKG | 0.49% | ― | ― | ― | $28.00K | <0.01% |
| TDNA | 0.44% | T. Rowe Price Biotech ETF | $11.32M | 0.55% | $49.28K | <0.01% |
| GWX | 0.13% | SPDR S&P International Small Cap ETF | $903.12M | 0.40% | $1.20M | 0.07% |
| ESIM | 0.13% | Eventide International ETF | $29.98M | 0.59% | $39.30K | <0.01% |
| OM3E | 0.10% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $1.35M | 0.08% |
| IBBQ | 0.10% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $119.16K | <0.01% |
| IBB | 0.09% | iShares Biotechnology ETF | $11.52B | 0.44% | $10.27M | 0.64% |
| TNXT | 0.08% | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | $15.46K | <0.01% |
| TMSL | 0.05% | T. Rowe Price Small-Mid Cap ETF | $3.21B | 0.55% | $1.66M | 0.10% |
| KFOR | 0.05% | iShares II PLC - iShares UK Foreign Focus UCITS ETF Accum- GBP | $2.59M | 0.28% | $1,338.67 | <0.01% |
| APIE | 0.02% | ActivePassive International Equity ETF | $1.13B | 0.45% | $241.93K | 0.01% |
| ISCF | 0.02% | iShares MSCI Intl Small-Cap Multifactor ETF | $719.78M | 0.23% | $143.33K | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $572.95K | 0.03% |
Popular ETF Comparisons
CMPS ETF Exposure FAQ
What ETFs hold COMPASS Pathways stock?
COMPASS Pathways (CMPS) is currently held by 23 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to CMPS include ARK (ARKG), AdvisorShares (PSIL) and Militia (ORR).
Which ETF has the largest exposure to CMPS?
The ETF with the largest exposure to CMPS is ARK (ARKG), with approximately $58.53M in market value exposure.
How much CMPS stock is held by ETFs?
ETFs currently hold approximately $81.77M worth of COMPASS Pathways (CMPS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.
